Levmentin (Amoxicillin, Clavulanic Acid)

Amoxicillin disrupts bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, leading to cell lysis. Clavulanic acid inhibits β‑lactamase enzymes that many resistant bacteria produce, protecting amoxicillin from degradation. This synergy broadens the antimicrobial spectrum to include β‑lactamase‑producing strains.

The exact dose of Levmentin is set by the prescribing clinician based on the type and severity of the infection, the patient’s age, weight, renal and hepatic function, and local antimicrobial guidelines. No fixed regimen is provided here; the prescriber tailors therapy to each individual case.

Safety data for Levmentin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss the risk‑benefit profile with the patient and consider alternative agents when appropriate.

To order Levmentin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling for injectables) and any required import documentation.

Plain amoxicillin lacks a β‑lactamase inhibitor, so it may be inactivated by bacteria that produce β‑lactamase enzymes. Levmentin adds clavulanic acid, which blocks those enzymes, extending coverage to resistant strains such as certain Haemophilus, Staphylococcus and anaerobic organisms. This makes Levmentin a broader‑spectrum option for mixed infections.

Levmentin should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution. Maintaining the cold chain preserves drug stability and potency.

Levmentin is supplied as an injectable solution for intravenous infusion. It is administered by a qualified healthcare professional under aseptic conditions, typically diluted in an appropriate IV fluid and infused over the period recommended by the prescriber, based on the infection being treated.

The most serious adverse events include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare but life‑threatening skin disorders like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Prompt medical attention is required if any of these symptoms develop.

Levmentin is contraindicated in patients with a documented hypersensitivity to amoxicillin, clavulanic acid, or any other β‑lactam antibiotics. It should also be avoided in individuals who have previously experienced severe reactions such as anaphylaxis or Stevens‑Johnson syndrome related to β‑lactam therapy.